Harms associated with retinal implantation of a stimulating electrode array to treat outer-retinal degeneration: a systematic review and meta-analysis of safety.

Abstract

Retinal implantation of an electrode array is an emerging treatment for vision loss caused by outer-retinal degeneration. This article collects and analyses harms associated with the treatment reported in the peer-reviewed literature, thus enabling informed decision-making by patients, clinicians, researchers, engineers, and policymakers. We searched MEDLINE, Embase, and clinical trials registries for peer-reviewed journal articles reporting harms outcomes. We extracted data from articles including study design, definitions of 'serious adverse event', and timing of adverse events. We applied the McMaster tool to these articles to assess the risk of bias in harms assessment and reporting. Our searches returned 585 abstracts. We reviewed the full text of 59 articles describing 11 different devices. McMaster scores ranged from 3 to 12 (maximum 15; higher scores indicate less risk). We compiled a comprehensive list of all serious and non-serious adverse events associated with retinal implantation. Several harms were common across devices. Our meta-analysis showed that serious adverse events are log-uniformly distributed throughout follow-up. Improved reporting and further clinical studies are needed to develop a reliable safety profile of retinal implantation. Our findings will help guide the design, conduct, and reporting of future clinical trials of retinal implantation and other emerging treatments for vision loss. (PROSPERO registration: CRD42022308123.).